ReviewInternational journal of molecular sciences2022

Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma.

Kostas Palamaris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.